[Prevention of cardiotoxic effects of anthracyclines in oncopediatric praxis].
Safonova
S A
SA
Gershanovich
M L
ML
Punanov
Iu A
IuA
D000293:Adolescent; D018943:Anthracyclines / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry*; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage / Q000009:adverse effects* / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D002648:Child; D002675:Child, Preschool; D004317:Doxorubicin / Q000009:adverse effects / Q000737:chemistry; D006331:Heart Diseases / Q000139:chemically induced / Q000517:prevention & control*; D006801:Humans
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin